As a pharmacist that has seen literaly 100's of people try to get off Cymbalta after finding it does absolutely nothing for them, I find it interesting that Lilly that "really ethical" drug company choose to put it in the doseage forms it comes in. As a compouding pharmacist I find myself spending more and more time helpoing physicains come upwith a means to taper patients off from this addicting drug. Try stopping it after a few months cold turkey and see what happens. ER visit with all kind of bizarre symptoms. Can Lilly make it anymore difficult to taper a dose of product? Zyprexa tablets that can't be split is bad enough, but really, how much time did you guys spend trying to come up this mess. A bunch of tiny pellets in a capsule that just have easily been put in in a tablet form that could be broken in hlves or quarters to get patients off this addictive drug. Lilly used to be a well thought of drug company, but of late all they do is raise prices of existing drugs, make impossible dosing formulations for tapering and kep some guy by the name of Taurel running the show. For what?? MONEY. All who work for Lilly should ask themselves what great innovative product have they come up in the last 10 years?? Don't insult my intelligence by telling me this is the only form that you could possibly make it in. It was done by design and you know it. In my area you are losing business faster than you are replacing it from the all medical specialists once they have to go through this in getting a patient off this drug. I no longer dispense "new" prescritions for Cymbalta and and send the patient down the road with the information I have about geting off it a mediocre drug at best. I tell them to think it over and get back to the prescriber. I have almost a full time job now just compounding alternative doseage forms to help those wishing to get a way from this Effexor like drug since the word has spread in our community that I have the means to take it on and do it successfully. Quit looking at the bottom line and start comming up with as you say "answers that matter" for the patient rather than answers that will fill the corporate back accounts. As for Zyprexa, the ethics of medicine do state "do no harm" but again you don't care about the patient, just that botom line and stock options. I am currently submitting data to Rep Waxman and Senator Grassley on this issue and hope they rake you guys big time for being the "bad players" you are in the pharmaceutical industry. Lilly is no longer the Lilly that once was top of the line in its field. Get back to what you can really do to help patients and not yourselves.